Description
Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We’ve employed a unique, decentralized model of nimble, focused companies (‘Vants’) focused on various therapeutic areas and built around the pursuit of innovation in drug development and technology.
Our model is different. Five new medicines have been approved off the Roivant platform; we’ve built five biotechs that have become public; we’ve created well over $1b in value in Roivant Health in just six years. Our successes have ranged from computational drug discovery to tokenized healthcare data exchange, and from novel topicals for dermatological conditions to ultrarare tissue therapies.
Roivant Health is Roivant’s platform for the creation of new technology Vants, focused on delivering improvements to human health outside of our traditional biotech platform. In six years since inception, we’ve created eight enduring companies and over $1B in enterprise value, including the leading deidentified healthcare data exchange platform (Datavant) and a top-tier computational drug discovery company (VantAI) which has partnered with Johnson & Johnson, Bristol-Myers Squibb, and Boehringer Ingelheim. Our goal is to improve human health by rapidly discovering, developing and delivering innovative medicines and technologies to all patients. Our success is predicated on attracting and retaining top talent, generating new ideas and promoting an open and collaborative culture.
We embrace diversity across all dimensions and levels of the organization, and we strive to ensure every employee is supported in reaching their full potential. We hire motivated people with diverse backgrounds, identities, experiences and skillsets. We are committed to fostering an inclusive culture where all employees feel valued, respected and empowered to create value for patients.
Position Summary
Roivant is seeking an Associate to support the incubation of new healthcare technology Vants. This role offers exposure to the full company creation process, from early-stage ideation to execution.
We prioritize rapid career advancement for high performers and take a flexible approach to role design, adjusting responsibilities based on individual strengths. The ideal candidate is ambitious, entrepreneurial, and comfortable with ambiguity, driven by a passion for building transformational healthcare businesses. We seek individuals who embrace calculated risk-taking as essential to achieving meaningful outcomes for patients.
Responsibilities
- Support early-stage ideation by identifying and evaluating potential opportunities based on key success factors, such as time to market, Roivant’s strategic advantages, validation pathway, and market potential
- Develop and execute structured workplans to assess incubation opportunities, conducting both quantitative and qualitative analyses of markets, competitors, product landscapes, and technology
- Assist in the initial stages of company building, contributing to product development, business development, operations, and fundraising
- Support leadership recruitment efforts by defining role profiles and sourcing candidates for new Vants
- Collaborate with incubated ventures, working directly with leadership teams during key business inflection points, such as fundraising or strategic pivots
Skills, Qualifications, and Requirements
- Candidates should have at least two years of relevant full time work experience
- Exceptional academic background
- Entrepreneurial mindset with a strong desire to operate in a fast-paced environment
- Intellectual curiosity and ability to navigate ambiguity
- Strong analytical and problem-solving skills, with the ability to execute at a high velocity
- Excellent communication skills, capable of engaging with executives and stakeholders
- Experience in venture building or product development, whether at a startup, within a larger organization, or in an incubation setting, ideally in healthcare or life sciences technology
Base salary for this role will be determined during the interview process and will vary based on multiple factors, including but not limited to prior experience, relevant expertise, current business needs, and market conditions. The expected base salary for the role will generally be between $135,000 to $150,000 per year at the commencement of employment, but the final salary offered may be outside this range based on individual circumstances and business and market conditions.
Base salary if hired is only part of the total compensation package, which, depending on the position, may also include other components such as discretionary bonuses, equity, and Company-sponsored benefit programs.
This position is at-will and Roivant reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance and business and market conditions.
Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
Similar jobs
Est. 175,000 USD
Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We’ve employed a unique, decentralized model of nimble, focused companie…
Est. 155,000 USD
Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We’ve employed a unique, decentralized model of nimble, focused companie…
Est. 132,500 USD
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiar…
Est. 175,000 USD
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiar…
Est. 100,000 USD
About Roivant Sciences Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by cr…
Est. 158,500 USD
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiar…
Est. 208,000 USD
Founded in Silicon Valley in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic.…
Est. 320,000 USD
Associate – New Ventures, Asset Selection RTW Investments RTW Investments, LP (“RTW”) is a global, full life-cycle investment and innovation firm dedicated to solving the most challenging, unmet patient needs. We are foc…
Est. 233,500 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 195,000 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 279,500 USD
Founded in Silicon Valley in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic.…
Est. 140,000 USD
PhaseV is a Boston-based technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform — accelerating decisions, de-risking trials, and driving more efficient portf…
Est. 160,000 USD
Imagine if you had the skills, knowledge, and teammates to both understand the root of the world’s most pressing problems and build the technologies and companies best positioned to solve them. RA Capital has done exactl…
Est. 150,000 USD
PhaseV is transforming clinical development through advanced AI and ML. With rapidly growing demand from top pharma, biotech companies, and CROs, we’re seeking a Senior Director of Business Development to help support an…
Est. 211,500 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 185,000 USD
At Vynamic, we partner with leading pharmaceutical and life sciences companies to address critical strategic, operational, and organizational challenges—from early-stage planning through commercialization and beyond. Our…
Est. 211,500 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 185,000 USD
At Vynamic, we partner with leading pharmaceutical and life sciences companies to address critical strategic, operational, and organizational challenges—from early-stage planning through commercialization and beyond. Our…
Est. 165,000 USD
Datavant is the data collaboration platform trusted for healthcare. Guided by our mission to make the world’s health data secure, accessible and actionable, we provide critical data solutions for organizations across the…
Est. 185,000 USD
At Vynamic, we partner with leading pharmaceutical and life sciences companies to address critical strategic, operational, and organizational challenges—from early-stage planning through commercialization and beyond. Our…
Est. 185,000 USD
At Vynamic, we partner with leading pharmaceutical and life sciences companies to address critical strategic, operational, and organizational challenges—from early-stage planning through commercialization and beyond. Our…
Est. 197,920 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 150,000 USD
PhaseV is transforming clinical development through advanced AI and ML. With rapidly growing demand from top pharma, biotech companies, and CROs, we’re seeking a Senior Director of Business Development to help support an…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 234,000 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 207,000 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 282,500 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 225,000 USD
Join Us in Tackling Autoimmune Disease at Its Root At Vor, we believe science can do more than manage symptoms. It can change the course of disease. By advancing telitacicept, a first- and potentially best-in-class dual…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 330,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…